Molecular magnetic resonance imaging with targeted contrast agents.
Magnetic resonance imaging (MRI) produces high-resolution three-dimensional maps delineating morphological features of the specimen. Differential contrast in soft tissues depends on endogenous differences in water content, relaxation times, and/or diffusion characteristics of the tissue of interest. The specificity of MRI can be further increased by exogenous contrast agents (CA) such as gadolinium chelates, which have been successfully used for imaging of hemodynamic parameters including blood perfusion and vascular permeability. Development of targeted MR CA directed to specific molecular entities could dramatically expand the range of MR applications by combining the noninvasiveness and high spatial resolution of MRI with specific localization of molecular targets. However, due to the intrinsically low sensitivity of MRI (in comparison with nuclear imaging), high local concentrations of the CA at the target site are required to generate detectable MR contrast. To meet these requirements, the MR targeted CA should recognize targeted cells with high affinity and specificity. They should also be characterized by high relaxivity, which for a wide variety of CA depends on the number of contrast-generating groups per single molecule of the agent. We will review different designs and applications of targeted MR CA and will discuss feasibility of these approaches for in vivo MRI.
Artemov
Dmitri
D
Department of Radiology, Division of MRI, Oncology Section, Johns Hopkins University School of Medicine, Traylor 217, 720 Rutland Avenue, Baltimore, Maryland 21205, USA. dmitri@mri.jhu.edu
D000345:Affinity Labels; D000818:Animals; D000911:Antibodies, Monoclonal; D002462:Cell Membrane / Q000378:metabolism; D002614:Chelating Agents; D003287:Contrast Media / Q000737:chemistry*; D005290:Ferric Compounds; D006801:Humans; D007089:Image Enhancement; D008279:Magnetic Resonance Imaging; D009682:Magnetic Resonance Spectroscopy; D051379:Mice
D000345:Affinity Labels; D000911:Antibodies, Monoclonal; D002614:Chelating Agents; D003287:Contrast Media; D005290:Ferric Compounds; C000499:ferric oxide